Literature DB >> 9578539

Basic mechanisms of epilepsy: targets for therapeutic intervention.

M A Dichter1.   

Abstract

Although a wide variety of drugs are available for treatment of epilepsy, many patients with epilepsy still experience uncontrolled seizures. In addition, there is a need for new drugs that can halt epileptogenesis after brain injury. Mechanisms that underlie seizure processes constitute potential target areas for the development of new antiepileptic drugs (AEDs). An understanding of the underlying mechanisms of interictal spike discharge and seizure spread is critical for the development of AEDs for treatment of partial seizures. Suppression of specific forms of voltage-dependent calcium currents and inhibition of GABA(B) receptor-mediated inhibition are two key target areas for new AEDs to treat primary generalized seizures. As researchers gain more understanding of the cellular, molecular, and genetic mechanisms underlying seizure propagation, we should be better able to develop therapeutic agents designed to suppress seizure-provoking mechanisms and to enhance the brain's natural protective mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9578539     DOI: 10.1111/j.1528-1157.1997.tb05200.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits inhibits Ca(2+) current in sympathetic neurons.

Authors:  A K Filippov; A Couve; M N Pangalos; F S Walsh; D A Brown; S J Moss
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

Review 2.  Future prospects for the drug treatment of epilepsy.

Authors:  A Nicolson; J P Leach
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes.

Authors:  L F Silva Brum; T Emanuelli; D O Souza; E Elisabetsky
Journal:  Neurochem Res       Date:  2001-03       Impact factor: 3.996

4.  Interictal to ictal transition in human temporal lobe epilepsy: insights from a computational model of intracerebral EEG.

Authors:  Fabrice Wendling; Alfredo Hernandez; Jean-Jacques Bellanger; Patrick Chauvel; Fabrice Bartolomei
Journal:  J Clin Neurophysiol       Date:  2005-10       Impact factor: 2.177

5.  Effects of blocking GABA degradation on corticotropin-releasing hormone gene expression in selected brain regions.

Authors:  V Tran; C G Hatalski; X X Yan; T Z Baram
Journal:  Epilepsia       Date:  1999-09       Impact factor: 5.864

6.  Clinical and metabolic correlates of cerebral calcifications in Sturge-Weber syndrome.

Authors:  Vinod K Pilli; Michael E Behen; Jiani Hu; Yang Xuan; James Janisse; Harry T Chugani; Csaba Juhász
Journal:  Dev Med Child Neurol       Date:  2017-04-11       Impact factor: 5.449

7.  Effects of gamma-decanolactone on seizures induced by PTZ-kindling in mice.

Authors:  Paulo Alexandre de Oliveira; Felipe Luis Lino; Shandale Emanuele Cappelari; Lucimar Filot da Silva Brum; Jaqueline Nascimento Picada; Patrícia Pereira
Journal:  Exp Brain Res       Date:  2008-02-05       Impact factor: 1.972

Review 8.  Electroencephalogram-based pharmacodynamic measures: a review.

Authors:  Michael Bewernitz; Hartmut Derendorf
Journal:  Int J Clin Pharmacol Ther       Date:  2012-03       Impact factor: 1.366

9.  Stability of synchronization clusters and seizurability in temporal lobe epilepsy.

Authors:  Agostina Palmigiano; Jesús Pastor; Rafael García de Sola; Guillermo J Ortega
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Emerging drugs for partial-onset epilepsy: a review of brivaracetam.

Authors:  Lan Gao; Shuchuen Li
Journal:  Ther Clin Risk Manag       Date:  2016-05-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.